Yanagawa T, Yoshida H, Yamagata K, Onizawa K, Tabuchi K, Koyama Y, Iwasa S, Shimoyamada H, Harada H, Omura K
Department of Oral and Maxillofacial Surgery, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
J Exp Clin Cancer Res. 2007 Jun;26(2):215-20.
Cytokeratin (CK) 13 is an intermediate filament protein that is expressed in a cell-type-specific manner, in the tongue and occasionally in tongue squamous cell carcinoma (SCC). Correlations between the clinical features of patients with SCC and CK13 expression in the tumor are here investigated along with CK13's utility as a marker for tongue cancer status. Samples from 121 patients with SCC of the tongue were examined by immunohistochemistry with antibodies against CK13. Correlations between the expression level of CK13 in the tumor and the patients' clinical features were statistically analyzed by univariate and multivariate methods. Univariate analysis showed a more relevant number of local recurrence (P = 0.04) in CK13-negative staining patients. In addition, CK13-negative cases were associated with local recurrence by multiple logistic regression analysis (OR: 3.36; 95% CI: 1.044-10.78; P = 0.04). Our results suggest that the loss of CK13 expression indicates tumors with a high potential for recurrence, and thus CK13 could be useful for determining the best course of treatment.
细胞角蛋白(CK)13是一种中间丝蛋白,以细胞类型特异性方式表达于舌部,偶尔也表达于舌鳞状细胞癌(SCC)中。本文研究了SCC患者的临床特征与肿瘤中CK13表达之间的相关性,以及CK13作为舌癌状态标志物的效用。采用抗CK13抗体通过免疫组织化学法检测了121例舌SCC患者的样本。通过单因素和多因素方法对肿瘤中CK13表达水平与患者临床特征之间的相关性进行了统计学分析。单因素分析显示,CK13阴性染色患者的局部复发次数更多(P = 0.04)。此外,通过多因素逻辑回归分析,CK13阴性病例与局部复发相关(OR:3.36;95%CI:1.044 - 10.78;P = 0.04)。我们的结果表明,CK13表达缺失表明肿瘤具有较高的复发潜能,因此CK13可用于确定最佳治疗方案。